Real-World Prevalence of Genetic Mutations in Female Breast Cancer Patients Aged Under 65 vs. 65 Years or Over in the United States Between 2014 and 2022
The Impact of the SARS-CoV-2 Pandemic (COVID-19) on the Incidence of Newly Diagnosed Multiple Myeloma Patients Using a Federated Network of Real-World Evidence in US and Germany
